JPM on tenterhooks over Novartis-Cytokinetics merger rumour

With M&A news coming thick and fast on the first day of the JP Morgan Healthcare conference in San Francisco, attendees were left hanging as proceedings closed with no

NICE backs Axonics’ rechargeable device for overactive bladd...